There are 2949 resources available
Genomic profiling is driving the precision oncology
Presenter: Philip Jermann
Session: Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days
Resources:
Webcast
Lung cancer diagnostic test needs: perspective from a thoracic oncologist
Presenter: Gabriela Fernandes
Session: Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days
Resources:
Webcast
Establishment of a large-scale Asian genomic screening platform to identify non-small cell lung cancer with rare driver oncogenes and clarify drug resistant mechanisms
Presenter: Koichi Goto
Session: Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days
Resources:
Webcast
NTRK, RET and other fusion biomarkers testing: Latest developments
Presenter: Philip Jermann
Session: Thermo Fisher Scientific - NGS Biomarker testing: Time matters . No longer need to wait for weeks, as this can now happen within days
Resources:
Webcast
Introduction
Presenter: Fortunato Ciardiello
Session: Servier - Can current treatment strategies for mCRC be further optimized?
Resources:
Webcast
Optimizing treatment strategies in first-line mCRC
Presenter: Mark Saunders
Session: Servier - Can current treatment strategies for mCRC be further optimized?
Resources:
Webcast
Extending the continuum of care beyond second-line mCRC
Presenter: Timothy Price
Session: Servier - Can current treatment strategies for mCRC be further optimized?
Resources:
Webcast
Conclusion
Presenter: Fortunato Ciardiello
Session: Servier - Can current treatment strategies for mCRC be further optimized?
Resources:
Webcast
Live Q&A - 24 September 2020 - 15:45-16:45
Presenter: Markus Möhler
Session: Bristol Myers Squibb - The future is now: Transforming management of GI cancer with immuno-oncology
Resources:
Webcast
Live Q&A - 24 September 2020 - 15:00-15:30
Presenter: George Demetri
Session: Pfizer Oncology - RWE and me: Multidisciplinary views on real-world evidence (RWE) in oncology
Resources:
Webcast